The Tapestri Platform is the first and only single-cell DNA sequencing platform to simultaneously detect single nucelotide variants (SNVs) and indels from the same cell. Move beyond the average readout from conventional bulk sequencing, and detect the underlying heterogeneity and rare cell populations in cancer research samples.
The average readout from conventional bulk sequencing misses the underlying genetic diversity across cell populations. Single-cell DNA sequencing provides the true measure of clonal heterogeneity without inferring or guessing.
Reveal the true clonal architecture in a tumor sample without the assumptions confounded by bulk sequencing.
Identify true mutation co-occurrence in clonal populations
Detect rare subclones down to 0.1% that may be missed by bulk sequencing
Determine the zygosity that matters for your disease research
See how single-cell DNA sequencing reveals clonal evolution in AML patients on gilteritinib.
Cathy Smith, M.D., University of California, San Francisco